Citizens Financial Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14.7M Buy
32,918
+10,108
+44% +$4.5M 0.24% 84
2025
Q1
$11.1M Buy
22,810
+116
+0.5% +$56.2K 0.22% 93
2024
Q4
$9.14M Buy
22,694
+577
+3% +$232K 0.18% 100
2024
Q3
$10.3M Sell
22,117
-7,356
-25% -$3.42M 0.21% 98
2024
Q2
$13.8M Buy
29,473
+99
+0.3% +$46.4K 0.31% 68
2024
Q1
$12.3M Sell
29,374
-422
-1% -$176K 0.41% 48
2023
Q4
$12.1M Sell
29,796
-323
-1% -$131K 0.42% 50
2023
Q3
$10.5M Sell
30,119
-1,503
-5% -$523K 0.43% 52
2023
Q2
$11.1M Sell
31,622
-11,557
-27% -$4.07M 0.4% 54
2023
Q1
$13.6M Sell
43,179
-751
-2% -$237K 0.5% 42
2022
Q4
$12.7M Sell
43,930
-1,770
-4% -$511K 0.5% 43
2022
Q3
$13.2M Buy
45,700
+222
+0.5% +$64.3K 0.59% 37
2022
Q2
$12.8M Sell
45,478
-2,411
-5% -$679K 0.54% 41
2022
Q1
$12.5M Buy
47,889
+389
+0.8% +$102K 0.44% 55
2021
Q4
$10.4M Buy
47,500
+42,987
+953% +$9.44M 0.35% 68
2021
Q3
$819K Buy
+4,513
New +$819K 0.03% 230
2020
Q3
Sell
-565
Closed -$164K 920
2020
Q2
$164K Sell
565
-42
-7% -$12.2K 0.01% 303
2020
Q1
$144K Sell
607
-58
-9% -$13.8K 0.01% 297
2019
Q4
$146K Buy
665
+389
+141% +$85.4K 0.01% 287
2019
Q3
$47K Buy
276
+180
+188% +$30.7K ﹤0.01% 373
2019
Q2
$17K Buy
96
+40
+71% +$7.08K ﹤0.01% 476
2019
Q1
$10K Sell
56
-25
-31% -$4.46K ﹤0.01% 503
2018
Q4
$13K Hold
81
﹤0.01% 390
2018
Q3
$16K Hold
81
﹤0.01% 405
2018
Q2
$14K Hold
81
﹤0.01% 375
2018
Q1
$13K Buy
+81
New +$13K ﹤0.01% 378
2016
Q4
Sell
-1,157
Closed -$101K 679
2016
Q3
$101K Sell
1,157
-32
-3% -$2.79K 0.01% 294
2016
Q2
$102K Buy
1,189
+253
+27% +$21.7K 0.01% 295
2016
Q1
$74K Buy
936
+31
+3% +$2.45K 0.01% 330
2015
Q4
$114K Buy
+905
New +$114K 0.01% 286